Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 78/100

Tandem Diabetes Care Inc at Robert W Baird Global Healthcare Conference Transcript

Sep 13, 2023 / 03:25PM GMT
Release Date Price: €21.52 (-1.56%)
Jeffrey D. Johnson
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

Good morning. Why don't we get started? My name is Jeff Johnson. I'm the Senior Medical Technology Analyst at Baird and our next presentation this morning is from Tandem Diabetes Care, the manufacturer, the t:slim Control-IQ insulin pump that has gained 25% to 30% share of the U.S. insulin pump market here in recent years. I think I'm right on that -- my math anyway. Yes, maybe more. I knew you were going to bristle at that point. With us today from Tandem we're happy to have Chief Executive Officer, John Sheridan; and Chief Financial Officer, Leigh Vosseller. John, I'll turn it over to you, and then we'll move into Q&A.

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Well, thanks, Jeff. Good morning, everybody. I'll just start off by saying that when you look at diabetes and specifically Type 1 diabetes in the U.S., it's a large and underpenetrated market. Today there's about 1.8 million people with Type 1 in the U.S., about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot